Financhill
Back

ZyVersa Therapeutics Stock Predictions

ZyVersa Therapeutics Stock Forecast

  • Is ZyVersa Therapeutics Stock Undervalued?
    The current ZyVersa Therapeutics [ZVSA] share price is $1.13. The Score for ZVSA is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.
  • ZVSA is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.

Will ZyVersa Therapeutics Stock Go Up Next Year?

Data Unavailable

ZyVersa Therapeutics Stock Rating

Data Unavailable

ZyVersa Therapeutics Stock Price History

Is ZVSA stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ZVSA is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
zyversa.com

52-Week Data

52-Week High:
42.39
52-Week Low:
1.04

Prediction Charts

Market Cap:
2.65M
Price in USD:
1.13
Volume:
132.61K
Beta:
0.66

Technical Analysis

SMA50:
1.98
SMA100:
2.68
SMA200:
4.44
52-Wk Change:
-96.06%

Stock Predictions

  • Is ZyVersa Therapeutics stock public?
    Yes, ZyVersa Therapeutics is a publicly traded company.
  • What is the ZyVersa Therapeutics stock quote today?
    The ZyVersa Therapeutics stock price is 1.13 USD today.
  • How to buy ZyVersa Therapeutics stock online?
    You can buy ZyVersa Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-5 2.66 2.54 3.37 2.35
Nov-6 1.88 1.54 1.88 1.34
Nov-7 1.45 1.52 1.89 1.45
Nov-8 1.58 1.40 1.67 1.27
Nov-11 1.43 1.30 1.43 1.23
Nov-12 1.25 1.25 1.35 1.20
Nov-13 1.26 1.25 1.28 1.17
Nov-14 1.22 1.13 1.22 1.10
Nov-15 1.12 1.08 1.14 1.04
Nov-18 1.18 1.24 1.27 1.10
Nov-19 1.24 1.23 1.29 1.21
Nov-20 1.13 1.15 1.19 1.10
Nov-21 1.14 1.14 1.18 1.11
Nov-22 1.13 1.13 1.13 1.06

ZyVersa Therapeutics Earnings

Data Unavailable

ZyVersa Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $1.35 per share, a decrease next quarter of $0.00 per share, an increase this year of $698.82 per share, and an increase next year of $11.20 per share.

* ZyVersa Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.